Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
2 hedge funds and large institutions have $0 invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
50% less funds holding
Funds holding: 4 → 2 (-2)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$89 |
PHIOW Hedge Fund Activity: Q1 2020 in Review
2 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q1 2020, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHIOW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $1K sold.
- 2 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q1 2020, down from 4 in Q4 2019.
- Funds reported $0 of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q1 2020, down 100% quarter-over-quarter.
- 1 fund opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q1 2020 and 2 closed out, a net change of -1 holder.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 seller in Q1 2020 was Susquehanna International Group, an estimated $1K sold.
Based on aggregated 13F filings for Q1 2020.